12.62
price down icon1.64%   -0.21
after-market アフターアワーズ: 12.62
loading
前日終値:
$12.83
開ける:
$12.4
24時間の取引高:
336.08K
Relative Volume:
1.10
時価総額:
$329.54M
収益:
-
当期純損益:
$11.77M
株価収益率:
21.82
EPS:
0.5785
ネットキャッシュフロー:
$-19.23M
1週間 パフォーマンス:
-17.03%
1か月 パフォーマンス:
-12.24%
6か月 パフォーマンス:
-52.66%
1年 パフォーマンス:
-44.18%
1日の値動き範囲:
Value
$12.04
$13.27
1週間の範囲:
Value
$12.04
$15.18
52週間の値動き範囲:
Value
$11.87
$29.79

Tourmaline Bio Inc Stock (TRML) Company Profile

Name
名前
Tourmaline Bio Inc
Name
セクター
Healthcare (1182)
Name
電話
646-481-9832
Name
住所
27 WEST 24TH STREET, NEW YORK
Name
職員
0
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
TRML's Discussions on Twitter

TRML を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TRML
Tourmaline Bio Inc
12.62 329.54M 0 11.77M -19.23M 0.5785
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.56 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.78 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
550.00 33.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.95 30.15B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
220.54 25.69B 3.81B -644.79M -669.77M -6.24

Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-06 開始されました Wedbush Outperform
2024-12-06 開始されました BMO Capital Markets Outperform
2024-11-11 繰り返されました H.C. Wainwright Buy
2023-12-15 開始されました Jefferies Buy
2023-12-04 再開されました H.C. Wainwright Buy
2023-11-17 開始されました Truist Buy
2023-10-31 開始されました Guggenheim Buy
2023-10-25 開始されました Piper Sandler Overweight
2022-10-20 開始されました H.C. Wainwright Buy
2022-07-05 ダウングレード Morgan Stanley Overweight → Equal-Weight
すべてを表示

Tourmaline Bio Inc (TRML) 最新ニュース

pulisher
Apr 06, 2025

Prudential Financial Inc. Cuts Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Apr 06, 2025
pulisher
Apr 03, 2025

Tourmaline Bio: We Should Wait For Upcoming Phase 2b Trial Data - Seeking Alpha

Apr 03, 2025
pulisher
Apr 03, 2025

Should You Invest in H&R Block Inc (HRB) Now? - News Heater

Apr 03, 2025
pulisher
Mar 31, 2025

Swiss National Bank Takes Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Mar 31, 2025
pulisher
Mar 25, 2025

Leading Factor Driving the Thyroid Eye Disease (TED) Market in 2025: Thyroid Disorders And Their Influence ... - WhaTech

Mar 25, 2025
pulisher
Mar 20, 2025

ProfittoPath - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Sold by AlphaQuest LLC - Defense World

Mar 20, 2025
pulisher
Mar 17, 2025

Tourmaline Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 17, 2025
pulisher
Mar 16, 2025

Alumis Inc. (NASDAQ:ALMS) Receives Average Recommendation of “Buy” from Brokerages - Defense World

Mar 16, 2025
pulisher
Mar 16, 2025

Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Mar 16, 2025
pulisher
Mar 16, 2025

Tourmaline Bio (NASDAQ:TRML) Stock Price Expected to Rise, Wedbush Analyst Says - Defense World

Mar 16, 2025
pulisher
Mar 16, 2025

HC Wainwright Raises Tourmaline Bio (NASDAQ:TRML) Price Target to $50.00 - Defense World

Mar 16, 2025
pulisher
Mar 14, 2025

H.C. Wainwright raises Tourmaline Bio stock target to $50 By Investing.com - Investing.com Canada

Mar 14, 2025
pulisher
Mar 14, 2025

Tourmaline Bio price target raised to $43 from $42 at Wedbush - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

H.C. Wainwright raises Tourmaline Bio stock target to $50 - Investing.com India

Mar 14, 2025
pulisher
Mar 14, 2025

Wedbush Lifts Price Target on Tourmaline Bio to $43 From $42, Keeps Outperform Rating - Marketscreener.com

Mar 14, 2025
pulisher
Mar 14, 2025

Novo Nordisk (0QIU) Gets a Buy from UBS - The Globe and Mail

Mar 14, 2025
pulisher
Mar 14, 2025

Tourmaline Bio’s 2024 Financial Results and Strategic Advances - TipRanks

Mar 14, 2025
pulisher
Mar 13, 2025

Tourmaline Bio shares fall as Q4 loss widens - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio shares fall as Q4 loss widens By Investing.com - Investing.com UK

Mar 13, 2025
pulisher
Mar 13, 2025

TOURMALINE BIO Earnings Results: $TRML Reports Quarterly Earnings - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio, Inc. SEC 10-K Report - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - The Manila Times

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio's cash position to provide cash runway into second half of 2027 -March 13, 2025 at 07:39 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio, Inc. Announces Over-Enrolled Phase 2 TRANQUILITY Trial and Strengthens Cardiovascular Scientific Advisory Board Amid Positive Financial Outlook - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business - Bluefield Daily Telegraph

Mar 13, 2025
pulisher
Mar 13, 2025

Tourmaline Bio Secures 2.5-Year Cash Runway with $294M, Accelerates Key Clinical Trials - StockTitan

Mar 13, 2025
pulisher
Mar 11, 2025

Tourmaline Bio (TRML) Projected to Post Earnings on Tuesday - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Wedbush Forecasts Tourmaline Bio FY2024 Earnings - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Tourmaline Bio (NASDAQ:TRML) Research Coverage Started at Wedbush - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Rhumbline Advisers Has $722,000 Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

Tourmaline Bio rises as Wedbush initiates with Outperform - MSN

Mar 06, 2025
pulisher
Mar 06, 2025

This Tourmaline Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - NewsBreak

Mar 06, 2025
pulisher
Mar 06, 2025

Wedbush bullish on Tourmaline Bio, initiates with an Outperform - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Wedbush Initiates Coverage on Tourmaline Bio With Outperform Rating, $42 Price Target - Marketscreener.com

Mar 06, 2025
pulisher
Mar 06, 2025

Wedbush Initiates Tourmaline Bio at Outperform With $42 Price Target -March 06, 2025 at 07:22 am EST - Marketscreener.com

Mar 06, 2025
pulisher
Mar 05, 2025

We Tested Over 25 Curling Irons. These 13 Are the Best - MarieClaire.com

Mar 05, 2025
pulisher
Mar 03, 2025

Tourmaline Bio to Present at the Leerink Partners Global Healthcare Conference 2025 - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

Volatus Aerospace and Draganfly Expand Collaboration to Service High-Value Geospatial Power Utility Customers - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

3 Reasons to Buy American Express Stock Like There's No Tomorrow - The Globe and Mail

Mar 03, 2025
pulisher
Mar 03, 2025

When and Where to Catch Tourmaline Bio's Next Investor Presentation - StockTitan

Mar 03, 2025
pulisher
Feb 28, 2025

Brokers Set Expectations for Tourmaline Bio FY2024 Earnings - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Truist maintains $74 target on Tourmaline Bio stock, reiterates buy By Investing.com - Investing.com UK

Feb 27, 2025
pulisher
Feb 27, 2025

Lifesci Capital Predicts Tourmaline Bio FY2024 Earnings - Defense World

Feb 27, 2025
pulisher
Feb 27, 2025

Financial Survey: X4 Pharmaceuticals (NASDAQ:XFOR) & Tourmaline Bio (NASDAQ:TRML) - Defense World

Feb 27, 2025
pulisher
Feb 26, 2025

Lifesci Capital Initiates Coverage on Tourmaline Bio (NASDAQ:TRML) - Armenian Reporter

Feb 26, 2025
pulisher
Feb 25, 2025

Tourmaline Bio (NASDAQ:TRML) Coverage Initiated by Analysts at Lifesci Capital - Defense World

Feb 25, 2025
pulisher
Feb 24, 2025

LifeSci Capital Initiates Coverage of Tourmaline Bio (TRML) with Outperform Recommendation - MSN

Feb 24, 2025
pulisher
Feb 24, 2025

Talaris Therapeutics stock hits 52-week low at $12.06 By Investing.com - Investing.com Australia

Feb 24, 2025
pulisher
Feb 24, 2025

Talaris Therapeutics stock hits 52-week low at $12.06 - Investing.com

Feb 24, 2025
pulisher
Feb 24, 2025

This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Feb 24, 2025

Tourmaline Bio Inc (TRML) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$60.29
price down icon 0.48%
$68.09
price down icon 1.58%
$17.32
price down icon 0.23%
$31.03
price down icon 0.26%
$86.82
price down icon 1.40%
biotechnology ONC
$220.54
price down icon 7.53%
大文字化:     |  ボリューム (24 時間):